Desflurane is an inhaled anesthetic gas used to put patients to sleep during surgery and keep them asleep throughout the procedure.[2] Suprane is currently approved and in use across 27 indications[4].[1]
Suprane is one of 501 small molecule programs targeting Fatigue. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
392 competitors in Obesity
Suprane
Actemra
Avapro
Amidate
Calciferol
Colcrys
Ultiva
Cetrotide
Spiriva
Flagyl
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Sep 18, 1992
SUPRANE
NDA NDA020118
Sources
Details